Pharmafile Logo

Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication

December 5, 2024 |  

We are pleased to share that The Evidence Base have carried out a ‘deep dive’ into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights for real-world impact. The presentation had previously been delivered to a full house at ISPOR Europe 2024 by Priti Jhingran, Smita Kothari, Dominic Jones-Phillips, and Carole Longson, MBE.

Genesis Research Group speakers

In a dynamic healthcare landscape defined by evolving policies, shifting payer expectations, and changing pricing thresholds, stakeholder insights are essential to maintaining the relevance, adaptability, and effectiveness of economic models in addressing the needs of patients and healthcare systems. By integrating perspectives from clinicians, payers, providers, and patients into the development process, economic models are better positioned to withstand rigorous scrutiny in access and reimbursement evaluations, increasing their robustness and applicability in the real-world healthcare environment.

At ISPOR Europe 2024 (November 17–20, 2024, Barcelona, Spain), the presentation, “Planning with Insights: Even the Best Economic Models Need Validation,” delved into this topic, exploring a roadmap for building robust, stakeholder-informed economic models that effectively support reimbursement decisions while addressing the complexities of global markets. Using a case study to illustrate the impact of insights on economic models, the session, which drew a capacity crowd, was led by Priti Jhingran (Genesis Research Group) and included contributions from Dominic Jones-Phillips (Genesis Research Group), Smita Kothari (Merck & Co., Inc.) and Carole Longson, MBE (consultant).

“When you bake in insights in early stages of model development, you really have a higher likelihood of having a relevant model, as well as scientifically robust methodology used to develop the model. And what’s most important is that you get the framework right for the model.”

Also at ISPOR Europe 2024, Genesis Research Group led an issue panel on ‘Precision or Perception: Strategic Drug Pricing Anchored on Evidence’ with Priti Jhingran, PhD, Genesis Research Group, Christopher Blanchette, PhD, MBA, Novo Nordisk, Frank-Ulrich Fricke, PhD, Technische Hochschule Nürnberg, and Adam Weston, MSc, Genesis Research Group.

If you’d like copies of the slides for either presentation, please contact solutions@genesisrg.com.

Read more on ‘Planning with Insights: Even the Best Economic Models Need Validation’

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

Genesis Research and Syapse combine forces to offer RWE and data to oncology innovators

Genesis Research is delighted to announce a strategic partnership with Syapse®, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations.

Genesis Research and Clinical Outcomes Solutions announce innovative partnership

International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes...

Genesis Research Acquires Market Access Transformation

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

GHO Capital Acquires Genesis Research

GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes...

Genesis Research: What is EVID AI?

Genesis Research Announces Significant Enhancements to EVID AI, the World's Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches